| Geld/Brief | 8,59 $ / 8,81 $ |
| Spread | +2,56% |
| Schluss Vortag | 9,11 $ |
| Gehandelte Stücke | 77.112 |
| Tagesvolumen Vortag | 384.464,4 $ |
| Tagestief 8,63 $ Tageshoch 9,02 $ | |
| 52W-Tief 8,63 $ 52W-Hoch 26,185 $ | |
| Jahrestief 8,63 $ Jahreshoch 25,38 $ | |
| Umsatz in Mio. | - |
| Operatives Ergebnis (EBIT) in Mio. | -147,06 $ |
| Jahresüberschuss in Mio. | -146,95 $ |
| Umsatz je Aktie | - |
| Gewinn je Aktie | -1,92 $ |
| Gewinnrendite | - |
| Umsatzrendite | - |
| Return on Investment | -62,87% |
| Marktkapitalisierung in Mio. | 615,92 $ |
| KGV (Kurs/Gewinn) | -9,98 |
| KBV (Kurs/Buchwert) | 8,71 |
| KUV (Kurs/Umsatz) | - |
| Eigenkapitalrendite | - |
| Eigenkapitalquote | +72,21% |
| Handelsplatz | Letzter | Änderung | Vortag | Zeit | |
|---|---|---|---|---|---|
| Frankfurt | 7,60 € | -5,59% | 8,05 € | 08:04 | |
| L&S RT | 7,95 € | -1,85% | 8,10 € | 18:23 | |
| Nasdaq | 8,63 $ | -5,27% | 9,11 $ | 18:04 | |
| NYSE | 8,725 $ | -3,70% | 9,06 $ | 18:07 | |
| NYSE American | 9,05 $ | 0 % | 9,05 $ | 15.10.26 | |
| Stuttgart | 7,65 € | -3,77% | 7,95 € | 18:03 | |
| Datum | Kurs | Volumen |
|---|---|---|
| 15.10.26 | 9,11 | 384 T |
| 14.10.26 | 8,87 | 273 T |
| 13.10.26 | 9,03 | 467 T |
| 12.10.26 | 9,55 | 0,62 M |
| 09.10.26 | 9,80 | 343 T |
| Zeitraum | Kurs | % |
|---|---|---|
| 1 Woche | 9,80 $ | -7,65% |
| 1 Monat | 11,79 $ | -23,24% |
| 6 Monate | 20,61 $ | -56,09% |
| 1 Jahr | 17,00 $ | -46,76% |
| 5 Jahre | 53,00 $ | -82,92% |
| Marktkapitalisierung | 615,92 Mio. $ |
| Streubesitz | 58,34% |
| Währung | USD |
| Land | USA |
| Sektor | Gesundheit |
| Branche | Biotechnologie |
| Aktientyp | ADR |
| +5,83% | MPM Oncology Impact Management LP |
| +2,96% | Siren, L.L.C. |
| +2,94% | Vivo Capital, LLC |
| +2,63% | Perceptive Advisors LLC |
| +2,33% | Baker Bros Advisors LP |
| +2,18% | Artisan Partners Limited Partnership |
| +2,09% | UBS Group AG |
| +1,52% | Morgan Stanley - Brokerage Accounts |
| +1,46% | Logos Global Management LP |
| +1,45% | Patient Square Capital LP |
| +1,34% | Artisan International Small-Mid Investor |
| +0,91% | Octagon Capital Advisors LP |
| +0,84% | ADAR1 Capital Management LLC |
| +0,84% | Ikarian Capital, LLC |
| +0,68% | Fidelity Advisor Biotechnology I |
| +0,65% | Redmile Group, LLC |
| +0,61% | Duquesne Family Office LLC |
| +0,60% | Ameriprise Financial Inc |
| +0,43% | Millennium Management LLC |
| +0,42% | Elmind Capital LP |
| +0,36% | Jane Street Group LLC |
| +0,29% | Ishara Investments LP |
| +0,09% | DWS ESG Biotech LC |
| +0,04% | A4Investments SICAV SIF ACCI IlanaA2EURH |
| +0,04% | Russell Inv US Small Cap Equity Y |
| +0,01% | ActivePassive International Equity ETF |
| +0,01% | Russell Inv US Small Cap Equity |
| +0,01% | Steward Values Enhanced International I |
| +0,01% | China Universal Gbl YLBJ QDII CNH |
| - % | Fidelity Nasdaq Composite Index |
| - % | Lord Abbett Global Hlth Cr IF GBP Acc |
| - % | Lord Abbett Health Care R6 |
| - % | Gabelli Health & Wellness |
| +41,665% | Institutionelle Aktionäre |
| +58,335% | Streubesitz |
| 29.11.2024 | Reverse Split | 5:1 |
| 07.06.2024 | Reverse Split | 2:1 |